Home > Newsletters > Devices & Diagnostics Letter > Industry: IRS Needs to Better Define ‘Taxable Use’ in Excise Tax Rule
Devices & Diagnostics Letter
May 14, 2012 | Vol. 39 No. 20
Industry: IRS Needs to Better Define ‘Taxable Use’ in Excise Tax Rule
Internal Revenue Service guidelines on the 2.3 percent medical device tax should make clear that manufacturers won’t have to pay taxes on products from which they derived no direct benefit, such as demonstration products and replacement parts provided free of charge, AdvaMed said in comments on a proposed rule on the tax.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.